May 13, 2022 | 6:30-8 PM EST | Zoom
General admission - $20
Students & Interns - Free
Please send RSVP to kristin@timh.org
This presentation aims to provide an introduction to ketamine, its historical uses and current applications in psychedelic-assisted psychotherapy. We will discuss how ketamine works as a pharmacological agent and consider existing outcome research to assist clinicians in determining who is a good candidate for this treatment. Attendees will learn how Ketamine-Assisted Psychotherapy (KAP) is structured and what to expect when referring a patient for KAP. The presentation will end with a Q&A session with the presenters.
Julie Schuck, LCSW (she/her) is a graduate of TI’s psychoanalysis program, and maintains a psychodynamic psychotherapy practice. Her interest in psychedelics as a tool for growth and healing led to a certificate in Psychedelic Integration Therapy through Fluence, and training in Ketamine Assisted Psychotherapy. Julie conducts KAP sessions through Journey Clinical in Brooklyn and Manhattan, and at the Woodstock Therapy Center team after relocating to upstate, NY. You can read more about her work here and here.
Liz Anable, PhD LMHC (she/they) holds a doctorate in Clinical Social Work from Smith College School for Social Work and her research focuses on integrating body-mind practices with accessible and trauma-informed evidenced-based clinical interventions. Liz is a Certified Somatic Experiencing® Practitioner and has advanced training in somatic psychotherapy, psychodynamic theory, psychedelic integration and ketamine-assisted psychotherapy. Liz teaches neuroscience, psychophysiology and trauma resilience to social work students at Columbia University and runs a private psychotherapy practice in Woodstock, NY where she supervises and trains therapists working toward their independent licensure. For more information visit elizabethanable.com.